日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes

利用自适应采样进行长读长纳米孔DNA测序,以鉴定酪氨酸激酶融合基因

Salmon, Matthew; Naumann, Nicole; Rinke, Jenny; Meggendorfer, Manja; Radia, Deepti; Pomfret, Mark; Ernst, Thomas; Hochhaus, Andreas; Reiter, Andreas; Tapper, William J; White, Helen; Cross, Nicholas C P

Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2Rα

抗原-IL-2 CAR增强子驱动CAR-T细胞的命运和干性,增强其在各种模型中的抗肿瘤疗效,且该作用独立于IL-2Rα。

Moravej, Heydar; Rakhshandehroo, Taha; Khan, Radia M M; Rivet, Victoria Marie; Marcandalli, Elodie; Mantri, Shreya R; Taklifi, Pegah; Lee, Uk-Jae; Louis, Benjamin B V; Munaretto, Leila A; Regan, Kathryn; Farkash, Zoe; Berland, Lea; Gabr, Zeina; Wolff, Alexandra N; Kowalewski, Antonia; Allen, Harris H; Nili, Ali; Baral, Jessika; Mercadante, Dayna; Fulciniti, Mariateresa; Jacobson, Caron A; Sperling, Adam S; Nadeem, Omar; Nia, Hadi T; Hemann, Michael; Munshi, Nikhil C; Rashidian, Mohammad

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

PI3Kα抑制剂和降解剂Inavolisib可利用FGFR2增强PIK3CA突变实体瘤患者和临床前模型的疗效。

Juric Dejan, Song Kyung, Johnson Radia M, Accordino Melissa K, Bedard Philippe L, Cervantes Andrés, Gambardella Valentina, Hamilton Erika, Italiano Antoine, Kalinsky Kevin, Krop Ian E, Oliveira Mafalda, Saura Cristina, Schmid Peter, Turner Nicholas C, Varga Andreea, Gendreau Steven, Hwang Michael S, Kuang Zheng, Lau Jeffrey T, Lin Eva, Pham Trang, Maddalo Danilo, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Martin Scott, Sodir Nicole M, Sokol Ethan S, Whitfield Zachary J, Wong Alice, Yauch Robert L, Aimi Junko, Cheeti Sravanthi, Fredrickson Jill, Hilz Stephanie, Hafner Marc, Hutchinson Katherine E, Jin Yanling, Peters Ubong, Zingg Daniel, Royer-Joo Stephanie, Shankar Noopur, Schutzman Jennifer L, Jhaveri Komal L, Dey Anwesha

Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib

莫美替尼治疗骨髓纤维化患者的免疫效应细胞可快速且持久地恢复

Makker, Jasmine; Thaw, Kyaw Htin; Sheikh, Amna; Cadman-Davies, Llywelyn; Duminuco, Andrea; Torre, Elena; Panetta, Margherita; Stanley, Conor; De Lavallade, Hugues; Curto-Garcia, Natalia; Sriskandarajah, Priya; O'Sullivan, Jennifer; Radia, Deepti H; Woodley, Claire; Narciso, Benissa; Asirvatham, Susan; Psaila, Bethan; Kordasti, Shahram; Harrison, Claire; Harrington, Patrick

Sparse Temporal AutoEncoder for ECG Anomaly Detection

用于心电图异常检测的稀疏时间自编码器

Daci, Radia; Taleb-Ahmed, Abdelmalik; Patrono, Luigi; Distante, Cosimo

First Identification of a Heterozygous RNU4-2 and RNU4-1 Deletion Associated With Fetal Urogenital and Anorectal Malformations

首次发现与胎儿泌尿生殖系统和肛门直肠畸形相关的RNU4-2和RNU4-1杂合缺失

Abaji, Mario; Gerard, Bénédicte; Nasca, Laurent; Fritih, Radia; Blanc, Julie; Castel, Pierre; D'Ercole, Claude; Levy-Mozziconacci, Annie

Investigating the effects of age and conditioning stimulation intensity on SMA-M1 connectivity in younger, middle-aged, and older adults

研究年龄和条件刺激强度对年轻、中年和老年人SMA-M1连接的影响

Tan, Jane; Rowe, Grant; Puri, Rohan; Needham, Merrilee; Marneweck, Michelle; Radia, Shivani; Vallence, Ann-Maree

Nurses' experiences of moral suffering: A qualitative interview study

护士的道德痛苦经历:一项定性访谈研究

Seidlein, Anna-Henrikje; Schilder, Michael; Miskine, Radia; Schöner, Alica; Mai, Tobias

A CAR enhancer increases the activity and persistence of CAR T cells

CAR增强剂可提高CAR T细胞的活性和持久性。

Rakhshandehroo, Taha; Mantri, Shreya R; Moravej, Heydar; Louis, Benjamin B V; Salehi Farid, Ali; Munaretto, Leila; Regan, Kathryn; Khan, Radia M M; Wolff, Alexandra; Farkash, Zoe; Cong, Min; Kuhnast, Adrien; Nili, Ali; Lee, Uk-Jae; Allen, Harris H; Berland, Lea; Simkova, Ester; Uslu, Safak C; Tavakolpour, Soheil; Rowley, Jennifer E; Codet, Elisabeth; Shahbazian, Haneyeh; Baral, Jessika; Pyrdol, Jason; Jacobson, Caron A; Nadeem, Omar; Nia, Hadi T; Wucherpfennig, Kai W; Rashidian, Mohammad

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

配体激活的 EGFR/MAPK 信号通路(而非 PI3K)是结直肠癌中 EGFR 疗法产生耐药性的关键机制

Qu Xueping, Hamidi Habib, Johnson Radia M, Sokol Ethan S, Lin Eva, Eng Cathy, Kim Tae Won, Bendell Johanna, Sivakumar Smruthy, Kaplan Benjamin, de Sousa E Melo Felipe, Mancini Andrew, Wongchenko Matthew, Shi Yi, Shames David, Yan Yibing, Ciardiello Fortunato, Bais Carlos